{"id":"W4281763071","doi":"10.1200/jco.2022.40.16_suppl.tps2078","title":"GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Agile software development; Clinical trial; Randomization; Biomarker; Glioblastoma; Oncology; Protocol (science); Internal medicine; Medical physics; Pathology; Cancer research; Alternative medicine; Computer science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03630756,0.0002920204,0.003181439,0.0002029842,0.0001195608,0.00002538395,0.0005863096,0.0003897188,0.00048468],"category_scores_gemma":[0.4283251,0.0002166816,0.0005736419,0.0005733899,0.0002853245,0.0001208036,0.0005903315,0.002176573,0.00001391861],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006788786,"about_ca_system_score_gemma":0.001406097,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000192808,"about_ca_topic_score_gemma":0.0001957539,"domain_scores_codex":[0.9842227,0.006615887,0.006929325,0.0005497696,0.001137316,0.0005450747],"domain_scores_gemma":[0.797241,0.1972292,0.003827814,0.0004047411,0.0004197562,0.0008775262],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.4556655,0.01069674,0.0006458139,0.00002424387,0.0003414437,0.001521175,0.0003009988,0.00008026112,0.00001240388,0.007000196,0.02380143,0.4999098],"study_design_scores_gemma":[0.3445121,0.1757967,0.00182966,0.0001452373,0.0005231844,0.0001711095,0.00063719,0.00178109,0.00001349838,0.4406825,0.03351871,0.0003890291],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"methods","genre_scores_codex":[0.9770418,0.0001489934,0.006772709,0.005442344,0.00783052,0.001901058,0.0001914064,0.00002712529,0.0006440817],"genre_scores_gemma":[0.4783106,0.0002094524,0.5167531,0.00228332,0.002152079,0.000171755,9.929289e-7,0.00004641567,0.0000723277],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.5099804,"threshold_uncertainty_score":0.9923242,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.6883699714316404,"score_gpt":0.658131808954005,"score_spread":0.03023816247763533,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}